1.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 4 and over
Sponsor: NCI
Protocol IDs: RPCI-I-72806, I 72806, NCT00536601
|
|
2.
|
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 2006-0374, NCT00539500
|
|
3.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: Any age
Sponsor: NCI
Protocol IDs: FHCRC-1803.00, 5606, NCT00068718
|
|
4.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and under
Sponsor: Other
Protocol IDs: ECP RIT, NCT00179790
|
|
5.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UPCC 20406, NCT00674427
|
|
6.
|
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 12 months to 21 years
Sponsor: NCI
Protocol IDs: COG-ADVL0812, ADVL0812, NCT00739427
|
|
7.
|
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 25
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: CHNMC-07053, 07053, CA180 121, NCT00788125
|
|
8.
|
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 21
Sponsor: NCI
Protocol IDs: COG-ADVL0912, ADVL0912, NCT00939770
|
|
9.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 19 months to 35 years
Sponsor: NCI
Protocol IDs: 070206, 07-C-0206, NCT00923351
|
|
10.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: Any age
Sponsor: NCI
Protocol IDs: MSKCC-03077, NCT00072358
|
|
11.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: PSCI-2003-232, NCT00084695
|
|
12.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: Over 1
Sponsor: Other
Protocol IDs: MSKCC-04148, NCT00107289
|
|
13.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 1 to 29
Sponsor: NCI
Protocol IDs: NANT-2001-02, NCT00253435
|
|
14.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Any age
Sponsor: Other
Protocol IDs: MSKCC-05122, NCT00445965
|
|
15.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 0 to 70
Sponsor: Other
Protocol IDs: 2006-0066, NCT00439556
|
|
16.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: V0706, CHRMS# 08-106, PRC # V0706, NCT00601003
|
|
17.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: Not specified
Sponsor: NCI
Protocol IDs: UMN-2007LS072, UMN-2007LS072, UMN-MT2007-07, NCT00617929
|
|
18.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 1 to 30
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: NANT-2007-01, NANT2007-01, NANT-MIP-IB13, NCT00659984, MIPI-NANT-2007-01
|
|
19.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: any age
Sponsor: Other
Protocol IDs: 2006-0752, NCT00698009
|
|
20.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 65 and under
Sponsor: Other
Protocol IDs: umcc 2007.137, HUM00017515, NCT00763490
|
|
21.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 6 months to 30 years
Sponsor: NCI
Protocol IDs: COG-ADVL0821, ADVL0821, NCT00831844
|
|
22.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 18
Sponsor: Other
Protocol IDs: NCH-08-0234, NCH 08-0234, IRB08-00234, NCT00874315
|
|
23.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 months to 13 years
Sponsor: Pharmaceutical / Industry
Protocol IDs: 3F8-NB-201, NCT00969722
|
|
24.
|
Phase: Phase I
Type: Treatment
Status: Active
Age: Over 9 months to 30 years
Sponsor: Other
Protocol IDs: NANT-99-02, 68, N99-02, CHLA-LA-NANT-99-02, CHLA-CCI-00.020, NCT00005835
|
|
25.
|
Phase: Phase I
Type: Treatment
Status: Active
Age: 5 to 20 years
Sponsor: NCI
Protocol IDs: UCCRC-11108B, NCI-4570, 4570, NCT00028522
|
